Home › Compare › PAVMZ vs DIVO

PAVMZ vs DIVO: Dividend Comparison 2026

PAVMZ yields 222222.22% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PAVMZ wins by $1.4076447531278624e+30M in total portfolio value
10 years
PAVMZ
PAVMZ
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076447531278624e+30M
Annual income
$1,406,399,782,569,334,400,000,000,000,000,000,000.00
Full PAVMZ calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — PAVMZ vs DIVO

📍 PAVMZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPAVMZDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PAVMZ + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PAVMZ pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PAVMZ
Annual income on $10K today (after 15% tax)
$18,888,888.89/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, PAVMZ beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PAVMZ + DIVO for your $10,000?

PAVMZ: 50%DIVO: 50%
100% DIVO50/50100% PAVMZ
Portfolio after 10yr
$7.038223765639312e+29M
Annual income
$703,199,891,284,667,200,000,000,000,000,000,000.00/yr
Blended yield
99.91%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PAVMZ buys
0
DIVO buys
0
No recent congressional trades found for PAVMZ or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPAVMZDIVO
Forward yield222222.22% ✓6.49%
Annual dividend / share$2.00$2.91 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.4076447531278624e+30M$30.7K ✓
Annual income after 10y$1,406,399,782,569,334,400,000,000,000,000,000,000.00 ✓$981.68
Total dividends collected$1.4075632434891558e+30M$8.2K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PAVMZ vs DIVO ($10,000, DRIP)

YearPAVMZ PortfolioPAVMZ Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$22,232,922$22,222,222.22$11,349$649.42+$22.22M → PAVMZ
2$46,198,082,523$46,174,293,296.41$12,833$688.83+$46198.07M → PAVMZ
3$89,718,752,943,223$89,669,320,994,923.30$14,459$727.90+$89718752.93M → PAVMZ
4$162,845,393,609,755,680$162,749,394,544,106,430.00$16,238$766.49+$162845393609.74M → PAVMZ
5$276,249,735,879,778,500,000$276,075,491,308,616,120,000.00$18,179$804.47+$276249735879778.47M → PAVMZ
6$437,989,462,258,048,500,000,000$437,693,875,040,657,100,000,000.00$20,293$841.71+$437989462258048512.00M → PAVMZ
7$649,026,142,700,674,900,000,000,000$648,557,493,976,058,700,000,000,000.00$22,591$878.14+$649026142700674875392.00M → PAVMZ
8$898,874,153,179,794,200,000,000,000,000$898,179,695,207,104,400,000,000,000,000.00$25,087$913.65+$8.988741531797941e+23M → PAVMZ
9$1,163,523,886,474,633,300,000,000,000,000,000$1,162,562,091,130,731,000,000,000,000,000,000.00$27,791$948.18+$1.1635238864746333e+27M → PAVMZ
10$1,407,644,753,127,862,300,000,000,000,000,000,000$1,406,399,782,569,334,400,000,000,000,000,000,000.00$30,718$981.68+$1.4076447531278624e+30M → PAVMZ

PAVMZ vs DIVO: Complete Analysis 2026

PAVMZ — Stock

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Full PAVMZ Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this PAVMZ vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PAVMZ vs SCHDPAVMZ vs JEPIPAVMZ vs OPAVMZ vs KOPAVMZ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.